Bullish Moving Averages
11
Bearish Moving Averages
5
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
1208.10Today’s High
1245.0052W low
825.0052W High
1541.60Open Price
1225.00Prev. Close
1086.7500Volume
48311.00Value
59456347.70Fundamentals
Market Cap Cr
2413.30
Price to Earnings
-47.40
Price to Book Value
5.80
Dividend Yield
0.10
PE to Growth
0.30
Op Revenue TTM Cr
431.40
Net Profit TTM Cr
-50.94
Cash From Operating Activity Cr
74.66
Return on Equity %
6.09
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
29 Apr, 2024
49.9
Week
44.3
Month
52.4
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
1227.93
PIVOT
First Resistance
1247.77
Second Resistance
1264.83
Third Resistance
1284.67
First Support
1210.87
Second Support
1191.03
Third Support
1173.97
Relative Strength Index
58.12
Money Flow Index
81.82
MACD
45.85
MACD Signal
56.44
Average True Range
52.96
Average Directional Index
44
Rate of Change (21)
11.48
Rate of Change (125)
4.08
Commodity Channel Index
12.3
Williams %R
-70.7
BETA
1 Month
1.63
3 Month
0.35
1 Year
0.09
3 Year
0.11
PRICE CHANGE ANALYSIS
↓ -0.94%
1 Week
Low
High
1200.1
1300.05
↑ 15.29%
1 Month
Low
High
1065.6
1336
↑ 22.9%
3 Months
Low
High
825.05
1336
↑ 2.34%
6 Months
Low
High
825.05
1336
↓ -7.6%
1 Year
Low
High
825.05
1541.65
| Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 51.69 | 111.74 | 144.55 | 129.54 | 120.96 | 203.73 | 186.97 | 278.78 | 175.31 | 103.47 | 129.46 | |
| Operating Expenses Qtr | 69.12 | 114.21 | 139.71 | 121.57 | 105.05 | 166.47 | 158.81 | 206.52 | 130.49 | 81.49 | 103.98 | |
| Operating Profit Qtr | -18.33 | -3.42 | 3.14 | 5.40 | 12.13 | 33.28 | 25.45 | 65.46 | 42.86 | 21.08 | 24.67 | |
| EBIDT Qtr Cr | -17.43 | -2.46 | 4.83 | 7.97 | 15.91 | 37.26 | 28.16 | 72.26 | 44.82 | 21.98 | 25.48 | |
| Depreciation Qtr | 8.72 | 9.17 | 9.40 | 7.77 | 8.81 | 8.18 | 8.94 | 10.66 | 9.07 | 8.17 | 6.52 | |
| Net Profit Qtr | -24.35 | -13.45 | -8.21 | -5.00 | 0.83 | 18.30 | 11.39 | 43.04 | 24.74 | 9.06 | 12.97 | |
| Basic EPS Qtr | -12.42 | -6.86 | -4.19 | -2.55 | 0.42 | 9.34 | 5.81 | 21.97 | 12.63 | 4.63 | 6.62 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 641.20 | 687.03 | 562.54 | 534.15 | 442.00 | |
| Operating Expenses Annual Cr | 551.90 | 522.48 | 443.37 | 437.02 | 354.49 | |
| Operating Profit Annual | 76.27 | 154.08 | 111.51 | 85.20 | 76.41 | |
| Operating Profit Margin Annual % | 11.89 | 22.43 | 19.82 | 15.95 | 17.29 | |
| Total Expenses Annual Cr | 606.35 | 565.99 | 473.87 | 472.88 | 386.21 | |
| EBIDT Annual Cr | 89.30 | 164.55 | 119.18 | 97.14 | 87.51 | |
| EBIDT Annual margin % | 13.93 | 23.95 | 21.19 | 18.19 | 19.80 | |
| Depreciation | 33.71 | 34.42 | 25.71 | 23.22 | 19.34 | |
| PAT Before ExtraOrdinary Items Annual Cr | 25.52 | 89.82 | 64.69 | 47.47 | 35.69 | |
| Net Profit Annual | 25.52 | 89.82 | 64.69 | 47.47 | 35.69 | |
| Basic EPS Annual | 13.02 | 45.85 | 33.05 | 24.27 | 18.26 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 418.79 | 395.98 | 308.70 | 246.44 | 202.46 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 33.73 | 9.75 | 46.23 | 6.78 | 9.46 | |
| Total Current Liabilities Annual Cr | 526.33 | 490.98 | 322.97 | 318.88 | 249.16 | |
| Total Capital Plus Liabilities Annual Cr | 978.85 | 896.71 | 677.90 | 572.10 | 461.09 | |
| Fixed Assets Annual | 444.95 | 362.71 | 328.38 | 217.79 | 185.62 | |
| Total Non Current Assets Annual | 480.75 | 378.90 | 347.47 | 240.41 | 212.69 | |
| Total Current Assets Annual | 498.09 | 517.81 | 330.43 | 331.69 | 248.40 | |
| Total Assets Annual | 978.85 | 896.71 | 677.90 | 572.10 | 461.09 | |
| Contingent Liabilities plus Commitments Annual Cr | 256.13 | 215.22 | 233.72 | 209.82 | 124.24 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 74.32 | 23.41 | -8.06 | 168.56 | 15.32 | |
| Cash from Investing Activity Annual | -112.07 | -103.57 | -73.11 | -73.81 | -52.50 | |
| Cash from Financing Annual Activity | 37.66 | 80.37 | 81.23 | -94.64 | 37.09 | |
| Net Cash Flow Annual | -0.09 | 0.22 | 0.06 | 0.11 | -0.08 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 213.61 | 202.06 | 157.60 | 125.94 | 103.55 | |
| ROE Annual % | 6.09 | 22.68 | 20.95 | 19.26 | 17.62 | |
| ROCE Annual % | 12.28 | 32.07 | 26.33 | 29.18 | 32.16 | |
| Total Debt to Total Equity Annual | 0.81 | 0.71 | 0.61 | 0.40 | 0.87 | |
| EBDIT Annual Margin % | 14.21 | 24.32 | 21.47 | 18.60 | 20.30 |
| Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 51.70 | 111.77 | 144.56 | 129.55 | 120.97 | 203.73 | 186.98 | 278.79 | 175.31 | 103.47 | 129.46 | |
| Operating Expenses Qtr | 69.13 | 114.21 | 139.72 | 121.57 | 105.06 | 166.47 | 158.82 | 206.52 | 130.49 | 81.49 | 103.99 | |
| Operating Profit Qtr | -18.33 | -3.42 | 3.13 | 5.40 | 12.12 | 33.28 | 25.45 | 65.46 | 42.86 | 21.08 | 24.67 | |
| EBIDT Qtr Cr | -17.42 | -2.44 | 4.84 | 7.98 | 15.91 | 37.26 | 28.16 | 72.27 | 44.82 | 21.98 | 25.47 | |
| Depreciation Qtr | 8.70 | 9.16 | 9.39 | 7.76 | 8.80 | 8.17 | 8.93 | 10.64 | 9.06 | 8.15 | 6.51 | |
| Net Profit Qtr | -24.33 | -13.43 | -8.19 | -4.98 | 0.84 | 18.31 | 11.40 | 43.05 | 24.75 | 9.08 | 12.98 | |
| Basic EPS Qtr | -12.41 | -6.85 | -4.18 | -2.54 | 0.43 | 9.34 | 5.82 | 21.97 | 12.63 | 4.63 | 6.63 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 641.23 | 687.03 | 562.79 | 534.54 | 442.06 | |
| Operating Expenses Annual Cr | 551.91 | 522.49 | 443.32 | 437.43 | 354.43 | |
| Operating Profit Annual | 76.25 | 154.07 | 111.56 | 85.18 | 76.47 | |
| Operating Profit Margin Annual % | 11.89 | 22.43 | 19.82 | 15.93 | 17.30 | |
| Total Expenses Annual Cr | 606.28 | 565.91 | 473.72 | 473.19 | 386.15 | |
| EBIDT Annual Cr | 89.31 | 164.54 | 119.48 | 97.11 | 87.63 | |
| EBIDT Annual margin % | 13.93 | 23.95 | 21.23 | 18.17 | 19.82 | |
| Depreciation | 33.65 | 34.36 | 25.66 | 23.16 | 19.35 | |
| PAT Before ExtraOrdinary Items Annual Cr | 25.59 | 89.88 | 65.07 | 47.53 | 35.77 | |
| Net Profit Annual | 25.56 | 89.86 | 65.05 | 47.51 | 35.74 | |
| Basic EPS Annual | 13.04 | 45.85 | 33.21 | 24.27 | 18.26 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 419.36 | 396.50 | 309.18 | 246.57 | 202.49 | |
| Minority Interest Liability Annual Cr | 0.19 | 0.16 | 0.14 | 0.33 | 0.31 | |
| Total Non Current Liabilities Annual Cr | 33.66 | 9.51 | 45.99 | 6.46 | 9.48 | |
| Total Current Liabilities Annual Cr | 526.20 | 490.59 | 322.28 | 318.36 | 248.80 | |
| Total Capital Plus Liabilities Annual Cr | 979.41 | 896.76 | 677.59 | 571.72 | 461.08 | |
| Fixed Assets Annual | 445.08 | 362.77 | 328.39 | 217.73 | 185.93 | |
| Total Non Current Assets Annual | 480.56 | 381.08 | 347.16 | 239.97 | 212.60 | |
| Total Current Assets Annual | 498.85 | 515.68 | 330.43 | 331.75 | 248.48 | |
| Total Assets Annual | 979.41 | 896.76 | 677.59 | 571.72 | 461.08 | |
| Contingent Liabilities plus Commitments Annual Cr | 256.17 | 239.82 | 233.75 | 274.87 | 124.29 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 74.66 | 23.60 | -8.16 | 168.44 | 15.29 | |
| Cash from Investing Activity Annual | -112.51 | -103.87 | -73.11 | -73.81 | -52.50 | |
| Cash from Financing Annual Activity | 37.77 | 80.48 | 81.34 | -94.53 | 37.09 | |
| Net Cash Flow Annual | -0.08 | 0.22 | 0.06 | 0.10 | -0.12 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 214.00 | 202.40 | 157.91 | 126.17 | 103.72 | |
| ROE Annual % | 6.09 | 22.66 | 21.03 | 19.26 | 17.64 | |
| ROCE Annual % | 12.28 | 32.05 | 26.40 | 29.18 | 32.16 | |
| Total Debt to Total Equity Annual | 0.81 | 0.70 | 0.60 | 0.40 | 0.87 | |
| EBDIT Annual Margin % | 14.21 | 24.31 | 21.53 | 18.58 | 20.33 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| ICICI PRUDENTIAL MULTICAP FUND | 5.3 | 74803185 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| ASHOK VISHWANATH HIREMATH | 1.99 | 74803179 | 0 | 0 |
| GODREJ AGROVET LIMITED | 64.76 | 74803182 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| ICICI PRUDENTIAL MULTICAP FUND | 5.3 | 74803185 |
| NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA SMALL CAP FUND | 2.39 | 74803186 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| SHREANS DAGA | 1.9 | 74803199 |
| KAUSHIK DAGA | 1.67 | 74803200 |
| HUF | 1.1 | 74803192 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Jul 21, 2023 | 1.5 | FINAL | - | Equity Share |
| Jul 19, 2022 | 1.5 | FINAL | - | Equity Share |
| Jul 22, 2021 | 1.5 | FINAL | - | Equity Share |
| Jul 16, 2020 | 1.5 | FINAL | - | Equity Share |
| Jul 18, 2019 | 1.5 | FINAL | - | Equity Share |
| Jul 19, 2018 | 1.5 | FINAL | - | Equity Share |
| Jul 17, 2017 | 1.5 | FINAL | - | Equity Share |
| Sep 15, 2015 | 1.25 | FINAL | - | Equity Share |
| Sep 15, 2014 | 1 | FINAL | - | Equity Share |
| Sep 02, 2013 | 0.75 | FINAL | - | Equity Share |
| Sep 13, 2012 | 0.5 | FINAL | - | Equity Share |
| Sep 15, 2011 | 0.5 | FINAL | - | Equity Share |
| Aug 12, 2010 | 1 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 02, 2024 | Audited Results | - |
| Jan 25, 2024 | Quarterly Results | - |
| Oct 27, 2023 | Quarterly Results & Others | - |
| Jul 27, 2023 | Quarterly Results | - |
| May 02, 2023 | Audited Results & Final Dividend | - |
| Jan 30, 2023 | Quarterly Results & Others | Inter alia, the Board may also consider and approve issuance of Debentures or debt securities upto such limit as may be deemed appropriate and approved by the Board. |
| Oct 28, 2022 | Quarterly Results | - |
| Jul 25, 2022 | Quarterly Results | - |
| May 02, 2022 | Audited Results & Final Dividend | - |
| Jan 25, 2022 | Quarterly Results | - |
| Oct 27, 2021 | Quarterly Results | - |
| Jul 28, 2021 | Quarterly Results | - |
| Apr 30, 2021 | Audited Results & Final Dividend | - |
| Jan 25, 2021 | Quarterly Results | - |
| Oct 29, 2020 | Quarterly Results | - |
| Jul 22, 2020 | Quarterly Results | - |
| May 05, 2020 | Audited Results & Final Dividend | - |
| Jan 30, 2020 | Quarterly Results | - |
| Oct 25, 2019 | Quarterly Results | - |
| Jul 26, 2019 | Quarterly Results | - |
| Apr 30, 2019 | Audited Results & Final Dividend | - |
| Jan 25, 2019 | Quarterly Results | - |
| Oct 26, 2018 | Quarterly Results | - |
| Sep 14, 2018 | Amalgamation | inter alia, to consider and approve Scheme of Amalgamation of the Company with Godrej Agrovet Limited (Holding Company). |
| Aug 01, 2018 | Quarterly Results | - |
| May 02, 2018 | Audited Results & Final Dividend | - |
| Jan 31, 2018 | Quarterly Results | - |
| Oct 25, 2017 | Quarterly Results | - |
| Jul 28, 2017 | Quarterly Results | - |
| May 04, 2017 | Audited Results & Final Dividend | - |
| Mar 25, 2017 | Others | Allotted 9,000 (Nine Thousand) Equity Shares of Face Value Rs.10/- each to the employees of the Company upon exercise of 9,000 (Nine Thousand) Options granted to them, at an exercise price of Rs.34/- |
| Jan 25, 2017 | Quarterly Results | - |
| Oct 27, 2016 | Quarterly Results | - |
| Jul 26, 2016 | Quarterly Results | Allotted 21,200 (Twenty One Thousand Two Hundred) Equity Shares of Face Value Rs.10/- each to the employees of the Company on exercise of Options granted to them, at an exercise price of Rs. 34/-. |
| May 04, 2016 | Audited Results | - |
| Jan 29, 2016 | Quarterly Results | 1. Appointment of Mr. Vijay Kashinath Khot as an Additional Independent Director of the Company with immediate effect; 2. Appointment of Dr. Brahma Nand Vyas as an Additional Independent Director. |
| Nov 06, 2015 | Quarterly Results | 1. Appointment Mr. N. B. Godrej as the Chairman of the Company. 2. Appointment of Mr. S. Varadaraj as an Additional Director of the Company. |
| Oct 12, 2015 | Others | Appointment of Mr. N. B. Godrej as Additional Director of the Company with immediate effect. |
| Jul 25, 2015 | Quarterly Results | - |
| May 16, 2015 | Audited Results & Dividend | - |
| Mar 05, 2015 | Re-appointment of Managing Director | Re-appointment of Mr. Janak Rawal as Whole Time Director subject to the approval of members. |
| Jan 31, 2015 | Qtrly Results & Allotment of Equity Shares | To consider allotment of 9,25,925 Equity Shares of Rs. 10/- each fully paid-up at Rs. 108/- per share (including a premium of Rs. 98/- per share) on preferential basis. |
| Dec 19, 2014 | To Consider Allotment of Equity Shares | To consider and approve the issue and allotment of Equity shares on Preferential basis of Rs.10,00,00,000/- (Rupees Ten Crores Only) including premium thereon, |
| Oct 18, 2014 | Quarterly Results | - |
| Aug 09, 2014 | Quarterly Results & Others | To alter Memorandum and Articles of Association of Company to give effect to item to increase the Authorised Capital of the Company. |
| May 30, 2014 | Audited Results & Dividend, Others | 1. Increase in Authorised Capital . 2. To alter Memorandum and Articles of Association of Company to give effect to item no. 3 & 4 above. Revised from 14/05/2014. |
| Jan 24, 2014 | Quarterly Results | - |
| Oct 23, 2013 | Quarterly Results | - |
| Sep 19, 2013 | Allotment of Equity Shares | For approving the Allotment of Equity Shares pursuant to the Conversion of Preferential Warrants convertible into Equity Shares. |
| Aug 12, 2013 | Quarterly Results | - |
| May 24, 2013 | Audited Results & Dividend | - |
| Feb 14, 2013 | Quarterly Results | - |
| Jan 04, 2013 | Conversion of Preferential Warrants | To Consider the Allotment of Equity Shares pursuant to the Conversion of Preferential Warrants convertible into Equity Shares. |
| Nov 12, 2012 | Quarterly Results | - |
| Aug 09, 2012 | Quarterly Results | - |
| May 28, 2012 | Audited Results, Dividend & Others | To appoint Non-Executive & Independent Director. |
| Feb 29, 2012 | Increase in Authorised Capital & Others | To increase Authorized Capital of the Company from Rs. 17,00,00,OOO/- to Rs. 20,00,00,OOO/- & to issuance of 16,00,000 Convertible Warrants into Equity Shares on preferential basis. |
| Feb 14, 2012 | Quarterly Results | - |
| Jan 04, 2012 | Appointment of Whole Time Director | To consider the followings: 1. Appointment of Mr. Janak Rawal as Whole Time Director, subject to the approval of members. 2. Re-appointment of Mr. Ashok V Hiremath as Chairman & Managing Director. |
| Nov 12, 2011 | Quarterly Results | - |
| Aug 10, 2011 | Quarterly Results | - |
| May 27, 2011 | Audited Results & Dividend | - |
| Feb 05, 2011 | Quarterly Results | - |
| Nov 10, 2010 | Quarterly Results | - |
| Aug 05, 2010 | Quarterly Results | - |
| May 24, 2010 | Audited Results & Dividend | - |
| Jan 28, 2010 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
26 Apr 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Intimation Of Changes In Senior Management Personnel
Kindly find enclosed the intimation for change in the Senior Management Personnel.
24 Apr 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Board Meeting Intimation for Intimation Of Board Meeting As Per Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 ,inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results for the Quarter and Financial Year ended 31st March, 2024 after these results are reviewed by the Audit Committee.
18 Apr 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Closure of Trading Window
This is in continuation of the intimation dated March 28, 2024, by which the Company had intimated the Stock Exchange regarding the closure of Trading Window for dealing in the securities of the Company. This is to further inform you that the Trading window will remain closed for some of the Designated Persons beyond the declaration of the Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2024 and until further intimation by the Company. The concerned designated persons have accordingly been intimated not to trade in (buy or sell) Equity Shares of the Company during the stated period.
10 Apr 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Kindly find enclosed the Certificate under Regulation 74(5).
10 Apr 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Certificate As Per Regulation 40(9) And 40(10) Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended March 31, 2024
Kindly find enclosed the certificate under Regulation 40(9) and 40(10).
10 Apr 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Compliance Certificate Under Regulation 7(3) Read With Regulation 7(2) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended March 31, 2024
Kindly find enclosed the compliance certificate.
10 Apr 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Kindly find enclosed the Outcome of Annual General Meeting held on July 27, 2023 along with requisite clarification.
28 Mar 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Closure of Trading Window
The Trading Window for dealing in securities of the Company will be closed from April 1, 2024 till 48 hours after the declaration of the Audited Financial Results for the Quarter and Financial Year ending March 31, 2024.
09 Mar 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Change in Management
This is to inform you that the re-appointment of Mr. Anurag Roy as the "Whole Time Director & Chief Executive Officer" has been approved by the Shareholders by passing of a Special Resolution on March 9, 2024 by way of Postal Ballot. The Voting Results and Scrutinizer''s Report have already been filed with the Exchange.
09 Mar 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Kindly find enclosed the outcome of the Postal Ballot.
